NCT03368144View on ClinicalTrials.gov

Belgian Trial Evaluating the ClearLumen II Peripheral Thrombectomy System Recanalization of (sub)acute Thrombotic Femoropopliteal Occlusions

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

August 5, 2019

Study Completion Date

October 7, 2021

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

ClearLumen II Peripheral Thrombectomy System

Patients will be treated with the ClearLumen Peripheral Stent Graft System

Trial Locations (3)

3600

Z.O.L., Genk

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT03368144 - Belgian Trial Evaluating the ClearLumen II Peripheral Thrombectomy System Recanalization of (sub)acute Thrombotic Femoropopliteal Occlusions | Biotech Hunter | Biotech Hunter